LCTXNYSEBiological Products, (No Diagnostic Substances)

Lineage Cell Therapeutics, Inc. (LCTX) earnings date, market-implied expected move, and options open interest by expiry

1.01

Closed16:00 ET

Open1.03Volume1.2MMkt cap$252.9MEPS-0.14

Day0.99 – 1.0335%52-wk0.88 – 2.0910%

LCTX

Lineage Cell Therapeutics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 5

after close · in 5 days

est.Q3 FY26

Calendar

Next report

Last report

−2.65%

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Largest filed tie

—

Supply chain

13F top-10 QoQ

+14.05%

shares held · 10 largest managers

13F · Jun 30 '26123d lag

129 managers

Top fund weight

0.01%

LCTX weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Lineage Cell Therapeutics (LCTX) is expected to report on Nov 5 after close (estimated date).

Implied vs realized

1 report

—≥ implied

Q2 FY26Aug 6 '26confirmed—▼−2.65%—

quarterimplied−5%0+5%realized×

Q2 FY26—▼−2.65%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Oct 27 close

1.66OI · 3 expiries · Oct 27 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

2010%Nov 2020d121+317%

1810%Dec 1848d0.072,533−3%0.07

1230%Mar 19139d0.062,193+5%0.06

ExpiryPutsCallsP/C

Nov 2020d2010%121+317%1.66

Dec 1848d1810%2,533−3%0.07

Mar 19139d1230%2,193+5%0.06

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

144.43%as filednet margin · revenue −38.03% QoQ · −61.34% YoY

Revenue$1M−38.03%

Gross profit$1M100.00%−38.03%

Operating income−$9M−834.71%−17.52%

Pre-tax income$0—

Net income$2M144.43%+132.24%

Cost of revenue$0—

Operating expenses$10M+7.23%

Tax$0—

Other income$10M+273.29%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

PPI ×1.04· ±3.7% vs ±3.5% · 11 releases

eventrelease day|move|up · n×base

PPIproducer prices±3.7%4 of 11×1.04

GDPgross domestic product±3.3%9 of 20×0.94

CPROFcorporate profits±2.9%3 of 12×0.82

PCEpersonal income & outlays±2.8%8 of 20×0.79

FOMCrate decision±2.7%12 of 25×0.76

NFPjobs report±2.3%4 of 10×0.65

CPIconsumer prices±2.1%4 of 11×0.60

Bar = avg |move| to ±4% · tick = ±3.5% avg day · ×base = |move| ÷ ±3.5% · min 6 releases

Earnings history

EPS -0.03 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 6 '26 · confirmed	-0.03	—
Q1 FY26	—	-0.03	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod